Literature DB >> 21364284

Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease.

Hans Zischka1, Josef Lichtmannegger, Sabine Schmitt, Nora Jägemann, Sabine Schulz, Daniela Wartini, Luise Jennen, Christian Rust, Nathanael Larochette, Lorenzo Galluzzi, Veronique Chajes, Nathan Bandow, Valérie S Gilles, Alan A DiSpirito, Irene Esposito, Martin Goettlicher, Karl H Summer, Guido Kroemer.   

Abstract

Wilson disease (WD) is a rare hereditary condition that is caused by a genetic defect in the copper-transporting ATPase ATP7B that results in hepatic copper accumulation and lethal liver failure. The present study focuses on the structural mitochondrial alterations that precede clinical symptoms in the livers of rats lacking Atp7b, an animal model for WD. Liver mitochondria from these Atp7b–/– rats contained enlarged cristae and widened intermembrane spaces, which coincided with a massive mitochondrial accumulation of copper. These changes, however, preceded detectable deficits in oxidative phosphorylation and biochemical signs of oxidative damage, suggesting that the ultrastructural modifications were not the result of oxidative stress imposed by copper- dependent Fenton chemistry. In a cell-free system containing a reducing dithiol agent, isolated mitochondria exposed to copper underwent modifications that were closely related to those observed in vivo. In this cell-free system, copper induced thiol modifications of three abundant mitochondrial membrane proteins, and this correlated with reversible intramitochondrial membrane crosslinking, which was also observed in liver mitochondria from Atp7b–/– rats. In vivo, copper-chelating agents reversed mitochondrial accumulation of copper, as well as signs of intra-mitochondrial membrane crosslinking, thereby preserving the functional and structural integrity of mitochondria. Together, these findings suggest that the mitochondrion constitutes a pivotal target of copper in WD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21364284      PMCID: PMC3068979          DOI: 10.1172/JCI45401

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

1.  Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity.

Authors:  F Gharahdaghi; C R Weinberg; D A Meagher; B S Imai; S M Mische
Journal:  Electrophoresis       Date:  1999-03       Impact factor: 3.535

2.  Quantitation of mitochondrial transmembrane potential in cells and in isolated mitochondria.

Authors:  N Zamzami; D Métivier; G Kroemer
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

3.  Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase.

Authors:  T D Rae; P J Schmidt; R A Pufahl; V C Culotta; T V O'Halloran
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

4.  Penicillamine, a new oral therapy for Wilson's disease.

Authors:  J M WALSHE
Journal:  Am J Med       Date:  1956-10       Impact factor: 4.965

5.  Isolation of methanobactin from the spent media of methane-oxidizing bacteria.

Authors:  Nathan L Bandow; Warren H Gallagher; Lee Behling; Dong W Choi; Jeremy D Semrau; Scott C Hartsel; Valerie S Gilles; Alan A Dispirito
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

6.  Oxidant injury to hepatic mitochondrial lipids in rats with dietary copper overload. Modification by vitamin E deficiency.

Authors:  R J Sokol; M Devereaux; G W Mierau; K M Hambidge; R H Shikes
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

Review 7.  Mitochondrial oxidative stress: implications for cell death.

Authors:  Sten Orrenius; Vladimir Gogvadze; Boris Zhivotovsky
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

8.  Mitochondrial structure and function in the untreated Jackson toxic milk (tx-j) mouse, a model for Wilson disease.

Authors:  Eve A Roberts; Brian H Robinson; Suyun Yang
Journal:  Mol Genet Metab       Date:  2007-11-05       Impact factor: 4.797

9.  Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, by S. A. Kinnier Wilson, (From the National Hospital, and the Laboratory of the National Hospital, Queen Square, London) Brain 1912: 34; 295-509.

Authors:  Alastair Compston
Journal:  Brain       Date:  2009-08       Impact factor: 13.501

10.  16-BAC/SDS-PAGE analysis of membrane proteins of yeast mitochondria purified by free flow electrophoresis.

Authors:  Ralf J Braun; Norbert Kinkl; Hans Zischka; Marius Ueffing
Journal:  Methods Mol Biol       Date:  2009
View more
  63 in total

1.  Bone demineralisation in a large cohort of Wilson disease patients.

Authors:  Karl Heinz Weiss; Mart Van de Moortele; Daniel Nils Gotthardt; Jan Pfeiffenberger; Jessica Seessle; Elena Ullrich; Evelien Gielen; Herman Borghs; Els Adriaens; Wolfgang Stremmel; Wouter Meersseman; Steven Boonen; David Cassiman
Journal:  J Inherit Metab Dis       Date:  2015-02-07       Impact factor: 4.982

Review 2.  Wilson's Disease in China.

Authors:  Juan-Juan Xie; Zhi-Ying Wu
Journal:  Neurosci Bull       Date:  2017-03-06       Impact factor: 5.203

Review 3.  The Endolysosomal System and Proteostasis: From Development to Degeneration.

Authors:  Bettina Winckler; Victor Faundez; Sandra Maday; Qian Cai; Cláudia Guimas Almeida; Huaye Zhang
Journal:  J Neurosci       Date:  2018-10-31       Impact factor: 6.167

4.  Targeted inactivation of copper transporter Atp7b in hepatocytes causes liver steatosis and obesity in mice.

Authors:  Abigael Muchenditsi; Haojun Yang; James P Hamilton; Lahari Koganti; Franck Housseau; Lisa Aronov; Hongni Fan; Hannah Pierson; Ashima Bhattacharjee; Robert Murphy; Cynthia Sears; James Potter; Clavia R Wooton-Kee; Svetlana Lutsenko
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-04-20       Impact factor: 4.052

5.  Hepatocellular Carcinoma: An Unusual Complication of Longstanding Wilson Disease.

Authors:  Deepak Gunjan; Neeti Nadda; Saurabh Kedia; Baibaswata Nayak; Shashi B Paul; Shivanand Ramachandra Gamanagatti; Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2016-09-21

6.  Wilson disease: At the crossroads between genetics and epigenetics-A review of the evidence.

Authors:  Dorothy A Kieffer; Valentina Medici
Journal:  Liver Res       Date:  2017-08-16

Review 7.  Copper transporters and chaperones: Their function on angiogenesis and cellular signalling.

Authors:  S R Bharathi Devi; Aloysius Dhivya M; K N Sulochana
Journal:  J Biosci       Date:  2016-09       Impact factor: 1.826

8.  Methanobactin reverses acute liver failure in a rat model of Wilson disease.

Authors:  Josef Lichtmannegger; Christin Leitzinger; Ralf Wimmer; Sabine Schmitt; Sabine Schulz; Yaschar Kabiri; Carola Eberhagen; Tamara Rieder; Dirk Janik; Frauke Neff; Beate K Straub; Peter Schirmacher; Alan A DiSpirito; Nathan Bandow; Bipin S Baral; Andrew Flatley; Elisabeth Kremmer; Gerald Denk; Florian P Reiter; Simon Hohenester; Friedericke Eckardt-Schupp; Norbert A Dencher; Jerzy Adamski; Vanessa Sauer; Christoph Niemietz; Hartmut H J Schmidt; Uta Merle; Daniel Nils Gotthardt; Guido Kroemer; Karl Heinz Weiss; Hans Zischka
Journal:  J Clin Invest       Date:  2016-06-20       Impact factor: 14.808

Review 9.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

10.  Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration.

Authors:  Xing Guo; Marie-Helene Disatnik; Marie Monbureau; Mehrdad Shamloo; Daria Mochly-Rosen; Xin Qi
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.